BRIEF-Bavarian Nordic to shift vaccine work to Denmark from Germany

Fri Jan 11, 2013 8:02am EST

Related Topics

Jan 11 (Reuters) - Bavarian Nordic A/S says: * consolidates its vaccine manufacturing in Denmark * to prepare its Kvistgaard facility for the future commercial production of its prostate cancer vaccine, Prostvac, and transfer its production of clinical trial material to the facility. * to close its operations in Berlin, Germany where it has been producing clinical trial material for its MVA-BN based vaccine candidates * planned changes do not affect company expectations for 2012 full year results